Australia Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027

Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
The Australian pharmaceuticals market had total revenues of $10.5 billion in 2022, representing a negative compound annual growth rate (CAGR) of 1.4% between 2017 and 2022.
0
R&D expenditure in Australia is only 1.8% of GDP, below the OECD average of 2.67%. Government spending on R&D has been declining, with an average of 0.61% since 2010-11.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Australia
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Australia
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Australia pharmaceuticals market with five year forecasts

Reasons to Buy

What was the size of the Australia pharmaceuticals market by value in 2022?
What will be the size of the Australia pharmaceuticals market in 2027?
What factors are affecting the strength of competition in the Australia pharmaceuticals market?
How has the market performed over the last five years?
What are the main segments that make up Australia's pharmaceuticals market?

1 Executive Summary

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape

2 Market Overview

2.1. Market definition
2.2. Market analysis

3 Market Data

3.1. Market value

4 Market Segmentation

4.1. Geography segmentation

5 Market Outlook

5.1. Market value forecast

6 Five Forces Analysis

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape

7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the most recent market developments?

8 Company Profiles

8.1. Pfizer Inc.
8.2. Aspen Pharmacare Holdings Ltd
8.3. GSK plc.
8.4. AstraZeneca PLC

9 Macroeconomic Indicators

9.1. Country data

10 Appendix

10.1. Methodology
10.2. Industry associations
10.3. Related research
10.4. About the Publisher

List of Tables

Table 1: Australia pharmaceuticals market value: $ billion, 2017-22
Table 2: Australia pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: Australia pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Pfizer Inc.: key facts
Table 5: Pfizer Inc.: Annual Financial Ratios
Table 6: Pfizer Inc.: Key Employees
Table 7: Pfizer Inc.: Key Employees Continued
Table 8: Aspen Pharmacare Holdings Ltd: key facts
Table 9: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 10: Aspen Pharmacare Holdings Ltd: Key Employees
Table 11: GSK plc.: key facts
Table 12: GSK plc.: Annual Financial Ratios
Table 13: GSK plc.: Key Employees
Table 14: GSK plc.: Key Employees Continued
Table 15: AstraZeneca PLC: key facts
Table 16: AstraZeneca PLC: Annual Financial Ratios
Table 17: AstraZeneca PLC: Key Employees
Table 18: AstraZeneca PLC: Key Employees Continued
Table 19: Australia size of population (million), 2018-22
Table 20: Australia gdp (constant 2005 prices, $ billion), 2018-22
Table 21: Australia gdp (current prices, $ billion), 2018-22
Table 22: Australia inflation, 2018-22
Table 23: Australia consumer price index (absolute), 2018-22
Table 24: Australia exchange rate, 2018-22

List of Figures

Figure 1: Australia pharmaceuticals market value: $ billion, 2017-22
Figure 2: Australia pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: Australia pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in Australia, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in Australia, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in Australia, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2022

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Pfizer Inc.
Aspen Pharmacare Holdings Ltd
GSK plc.
AstraZeneca PLC

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€311EUR$350USD£274GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€467EUR$525USD£411GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€623EUR$700USD£548GBP

Key Highlights

Scope

Reasons to Buy

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Pharmaceutical Drugs Market Opportunities and Strategies to 2033

Pharma 5.0 Market Report 2025

Pharmaceutical Drugs Industry: Competitive Landscape 2023

Pharmerging - Global Strategic Business Report

Innovative Medicine Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application